Purpose. Candida species have become resistant to commonly used anti-fungal drugs like fluconazole and echinocandins. In our screen, a series of quaternary ammonium compounds (QACs) emerged as an alternative treatment choice for drugresistant Candida infections.
INTRODUCTION
In recent years, fungal infections have emerged as a serious public health concern worldwide [1, 2] . Candida albicans is one of the most contagious human fungal pathogens that lives in both yeast and filamentous forms [3, 4] . Patients with significant immune suppression frequently develop Candida esophagitis, which is one of the leading causes of fungal mortality [5, 6] . Conventional anti-fungal agents used for the treatment of candidiasis are polyenes (amphotericin B, nystatin) [7] , azoles (fluconazole, ketoconazole and posaconazole) [8] and echinocandins (caspofungin, micafungin) [9] . Major limitations associated with these drugs are their narrow therapeutic index, poor bioavailability, severe side effects and the emergence of resistant strains [10, 11] . These reasons are compelling researchers to explore new anti-fungals for treatment of lethal and drugresistant mycoses [12, 13] . Recently emerging small molecules such as peptides, alkane nitriles, boron compounds, cyclic guanidines, pyridine derivatives and quinolinium salts, are promising alternatives to overcome the limitations of the existing drugs [14] . Moreover, compounds targeting the fungal cell wall [b-(1,3)-D-glucan synthase inhibitors, e.g. chitin synthase, mannoprotein], cell membrane (lanosterol 14a-demethylase inhibitors, e.g. squalene epoxidase, inositol phosphoceramide synthase), DNA and protein synthesis (N-myristoyl transferase, aminoacyl-tRNA synthetase) and signal transduction pathways (calcineurin, electron transport chain) are equally promising [15] [16] [17] .
Furthermore, cationic agents are an important class of antiinfectives; specifically quaternary ammonium compounds (QACs) are largely recognized as anti-septics and disinfectants [18] [19] [20] . Cationic agents hypothetically react with the phospholipid components of the cytoplasmic membrane, thereby producing membrane distortion and a net positive charge on microbial cells [21] . The positive charge on microbial cells is often correlated with their biocidal action. Molecules with a net positive charge are able to kill microorganisms both in solution and in adherent state (upon adsorption to surfaces or bilayers) [22, 23] . The inhibition of adherent cell/biofilm by QACs gives them an edge over conventional anti-fungals [24, 25] . In particular QACs, such as didecyldimethylammonium chloride and benzyldimethyldodecyl ammonium chloride, with medium alkyl chains (six-twelve carbon) are prominent biocidal molecules [26] . However, due to severe toxicity, their usage is limited to topical applications mostly as hand and dishwashers [19] . In this study, we have tested some QACs that are highly effective as anti-fungals and at the same time much less toxic than molecules reported earlier. We believe that the addition of the oxazole moiety may be responsible for the reduced toxicity observed in these molecules and paves the way for the synthesis of non-toxic QACs in the future.
In modern medicinal chemistry, the concept of hybrid molecules has become a popular tool for the design and development of novel biologically active molecules with improved efficacy and reduced toxicity when compared to the parent compounds [27] . Based on this perception, we envisaged that conjugation of medium alkyl twin chain QACs with bioactive heterocycles would produce anti-fungal hybrid QACs with better toxicity profiles (Fig. 1) . To begin with, we have chosen oxazole as the model heterocycle to test our hypothesis. Oxazole structural motifs are well known in both synthetic and medicinal chemistry due to their occurrence in a wide range of bioactive substances [28] . For instance, oxazole-based natural products, benzoxazole A [29] , phorboxazole [30] and ulapualide A [31] exhibit anti-fungal properties. Here, we report the synthesis of oxazole-containing QACs 5(a-h) and 6(a-h) with a two-carbon spacer between the positive charge and oxazole moiety. Also, this report illustrates the potent antiCandida activity of the above lipids.
METHODS

Synthesis of cationic lipo-oxazole
Synthesis of the cationic lipo-oxazoles, 5(a-h) and 6(a-h), was carried out via the route shown in Fig. 2 . A facile metal-free method for the synthesis of oxazole derivatives was used as reported previously [32] . Based on this method, oxazole core 2 was synthesized from a mixture of amide 1a or 1b and Nbromo succinimide in the presence of DCE (1, 2 dichloroethane) at 100
C to obtain the desired heterocyclic cores 2a/2b with 89 % yield. Hydrolysis of 2a/2b afforded the acid fragment 3a/3b in 80 % yield. Next, coupling reactions were carried out with mono-Boc-protected ethylene diamine using EDCI (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) to obtain the amide derivative 4a/4b, in 70 % yield. After that, Boc-deprotection using trifluoro acetic acid (TFA)/dichloromethane (DCM) followed by alkylation by respective alkyl bromide, (since oxazole-lipid hybrids differed only in chain lengths) offered the twin chain tertiary amine intermediates with C6-C13 carbon atoms. Subsequent quaternization of tertiary amines with methyl iodide produced the desired derivatives 5(a-h) and 6(a-h) in good yields. The 1 H-NMR and 13 C-NMR spectra of all prepared compounds and precursors are in total agreement with the suggested structures. Additional support of the proposed structures comes from mass spectral data electrospray ionization-high resolution mass spectrometry (ESI-HRMS) and IR spectra data (available in the online version of this article).
Chemicals and strains C. albicans, ATCC 90028 strains were obtained from the CSIR-Institute of Microbial Technology, Chandigarh, India. Gu4/Gu5 and DSY294/DSY296 (matched pairs of fluconazole susceptible and resistant clinical isolates) were kind gifts from Joachim Morschhauser, Wurzburg, Germany and Dominique Sanglard, Lausanne, Switzerland, respectively [33, 34] . Roswell Park Memorial Institute (RPMI)-1640 with L-glutamine and without sodium bicarbonate (Gibco) was buffered with 165 mM 3-[N-morpholine] propane sulphonic acid (MOPS) pH 7.0, and filter sterilized. Fluconazole was used as a standard drug and purchased from Sigma-Aldrich Chem. All other media components and chemicals were obtained from Hi-Media Laboratories, Mumbai, India.
Culture conditions
Strains were stored as frozen stocks at À80 C. For reviving cultures, frozen stocks were thawed and plated on yeast extract peptone dextrose (YPD) agar plates. Single colonies from YPD plates were picked and inoculated into 10 ml of YPD broth in a 50 ml culture tube, and incubated at 30 C for 24 h, in a shaking incubator at 150 r.p.m. Cells from the activated culture were harvested by centrifugation for 5 min at 3000 r.p.m., washed thrice with PBS and resuspended in PBS for further experiments.
Growth inhibition assay (MIC determination)
The effect of test compounds on the growth of planktonic cells of C. albicans was studied by using the standard broth microdilution method as per Clinical and Laboratory Standards Institute Guidelines M27-A3 [35] . Briefly, an inoculum of 1Â10 3 cells was added to each well of 96-well plates with varying compound concentrations, up to a final volume of 200 µl and the microplates were incubated at 37 C for 48 h. Absorbance was measured by a plate reader at 595 nm (Epoch Microplate Spectrophotometer). Wells without test compounds were taken as growth controls. Wells with media only served as the blank. Various fluconazole concentrations were used as a standard anti-fungal. The percentage of growth inhibition was calculated considering the growth of cells without the inhibitor as 100 %, and the compound concentration showing no visible growth or !90 % of cell growth inhibition, when quantified spectophotometrically, was considered as the MIC concentration. The lowest test compound concentration that caused a 50 per cent reduction in the absorbance compared to that of growth control was considered as the IC 50 concentration of the test compound. 
Adhesion inhibition assay
The effect of cationic lipid-oxazoles on adherence of C. albicans to polystyrene coated 96-well plates was studied by using microplate-based assay [36] . Overall, 100 µl of 1Â10 7 cells ml À1 was allowed to adhere to the polystyrene surface of 96-well plates, in the presence of various test compound concentrations in PBS. Growth control and media only control was used to determine 100 % adhesion and zero growth (blank) respectively. According to the procedure, plates were incubated at 37 C for 90 min at 100 r.p.m. in an orbital shaker to allow attachment of cells on the surface and then washed with PBS to remove non-adherent cells. Adhesion of cells was observed under an inverted light microscope. Wells without test compounds served as the growth control and were considered to represent 100 % cell adhesion. Wells with media alone served as the blank.
Inhibition of biofilm formation C. albicans biofilms were developed on the polystyrene surface of 96-well plates as per standard methodologies [36] . In total, 100 µl of 1Â10 7 cells ml À1 cell suspension in PBS was inoculated, and plates were incubated at 37 C for 90 min to allow attachment of cells on the surface. Non-adhered cells were removed by washing three times with sterile PBS. To observe the effect on biofilm formation, RPMI-1640 medium with varying test compound concentrations were added immediately after the adhesion phase, and the plates were incubated for 48 h, at 37 C. After incubation, wells were washed to remove any planktonic cells, and biofilms were observed using an inverted light microscope. Photographs were taken, and biofilm growth was analysed with a 3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide (MTT) metabolic assay.
Quantitation by an MTT assay Live cells were quantified using an MTT assay. Overall, 10 µl of MTT solution (5 mg ml
À1
) was added to each well. Plates are incubated for 3 h at 37 C. Cells were checked for the appearance of punctuating or purple colour precipitate of formazan under an inverted microscope. In total, 100 µl of DMSO was added to each well to solubilize formazan. Absorbance was measured at 595 nm. Wells without a test compound were considered as the control, while those without cells were the blank [37] .
Haemolysis assay and cytotoxicity studies Human red blood cells (RBCs) were collected in a tube containing the anti-coagulant dextrose and citrate salt (containing 2.45 g dextrose, 0.73 g citrate and 2.2 g sodium citrate dehydrate per 100 ml water). RBCs were harvested by centrifugation for 2 min at 3000 r.p.m. at room temperature and were washed three times in PBS. A stock 1 % cell suspension was prepared from the pellet by dilution in PBS. Altogether, 0.5 ml of this stock suspension and 0.5 ml of the test compound diluted in PBS were mixed and incubated at 37 C for 30 min. After the incubation, cells were centrifuged at 3000 r.p.m. for 2 min at room temperature. The supernatants were used for determining absorbance at 450 nm. Total haemolytic activity (positive control) was achieved with 1 % Triton X-100 solution, and the solution containing RBCs without any drugs was used as the blank. Percentage of haemolysis was calculated using formula [38] :
[(A450 of the treated sample À A450 of the buffer-treated sample) Â 100 %/(A450 of Triton X 100 the treated sample À A450 of the buffered treated sample)] Cellular toxicity in the presence of the test compound was determined by the MTT assay [39] . Briefly, a different number of DU-145 (human prostate cancer) and NIH-3T3 (mouse fibroblast cell) cells in 100 µl volume of media (supplemented with 10 % FBS) were plated in each well of 96-well cell culture plates. Cells were adhered and then treated with different concentrations of compound for 48 h and proceeded for the MTT assay as described previously.
Electron microscopy
Morphological effects of active compound 5c on C. albicans was investigated using SEM. Briefly, 1Â10 6 C. albicans cells (ATCC 90028) were incubated for 24 h with 0.8 µg ml
À1
(1/2ÂMIC) of 5c in YPD broth. Samples were processed as reported earlier [40] and analysed under an FEI Quanta 250 SEM using an SE detector.
Statistical analysis
All experiments were conducted in triplicate and the values mentioned are the means of three biological replicates.
RESULTS
Anti-Candida activity of cationic lipo-oxazoles
After synthesis and purification, compounds 5(a-h) and 6 (a-h) were evaluated for their in vitro anti-fungal activities against C. albicans strain ATCC 90028, using a broth microdilution assay. Results are provided in Table 1 and hybrids 5c, 6a, 6b and 6c showed concentration-dependent growth inhibition of C. albicans with IC 50 values of 0.9, 4.6, 1.5 and 2.4 µg ml À1 respectively. These results clearly demonstrate that of all the tested conjugates, compounds containing specific chain length methylene linkers acts as potential anti-fungal agents. This study reveals that seven and eight carbon chain cationic lipids are suitable partners for oxazoles to generate fungicidal activity and the eight carbon chain containing QAC (5c) was the most effective among the tested QACs with IC 50 of 0.9 and MIC of 1.6 µg ml
À1
. After that, we tested 5c against matched pairs of clinical isolates Gu4/Gu5 and DSY294/296, as well as against non-albicans Candida strains. Clinical isolates Gu4/Gu5 and DSY294/DSY296 were pairs of fluconazolesensitive and resistant strains, which were isolated from the same patients during early and late episodes of candidiasis. The compound 5c demonstrated anti-fungal activity against both sensitive and resistant clinical isolates and non-albicans Candida strains at comparably low concentrations with MIC ranging from 1.6 to 6.2 µg ml À1 (Table 2) . These results indicate the broad-spectrum antiCandida activity of 5c.
Cationic lipo-oxazole 5c inhibits Candida cell adhesion to polystyrene surfaces Cationic lipo-oxazole compound 5c was evaluated for its ability to inhibit Candida cell adhesion to polystyrene surfaces. We tested the activity of lipo-oxazole 5c on Candida cell adhesion, which is the first stage in the formation of a biofilm. Adhesion of C. albicans to the polystyrene surface, prosthetic substrate and host tissue leads to colonization Table 1 . Anti-fungal activity of lipo-oxazoles in C. albicans ATCC 90028
Compound
Chemical structure Activity at 10 µg ml and is an important step leading to biofilm formation, drug resistance and disseminated candidiasis. Standard azoles and polyenes are unable to inhibit adhesion and as a result drug resistance develops due to evasion of persister cells. Percentage inhibition was quantified using the MTT metabolic assay at different concentration of 5c and is plotted as a bar graph with standard error of mean. 5c demonstrated about 60 % reduction in adhesion at the concentration range of 12.5 µg ml À1 compared to growth control in which no drug was added (Fig. 3b) . Microscopic examination also revealed inhibition of adhesion by the lipidated oxazole compound 5c (Fig. 3a) .
Cationic lipo-oxazole 5c inhibits Candida biofilm formation Biofilm formation by Candida passes through phases like adhesion, early phase, developmental phase and maturation. Having observed that 5c could inhibit adhesion, its role in biofilm formation was also evaluated. We observed that 5c could also inhibit biofilm formation in C. albicans. 10 6 cells of C. albicans were allowed to grow and adhere to the polystyrene coated wells of 96-well plates. 5c was added at different concentrations just after the adhesion phase (90 min), to observe its effect on Candida biofilm formation. 5c inhibited biofilm formation by 80 % at a concentration of 12.5 µg ml À1 when quantified using the MTT assay. Percentage inhibition was plotted as a bar graph with standard error of mean (Fig. 3d) . Microscopic examination also confirmed inhibition of biofilm formation by 5c (Fig. 3c) .
Cytotoxicity studies of cationic lipo-oxazole 5c
Cationic amphiphiles exhibit biocidal activity by binding and disrupting the membrane bilayers of microbes. To gain some insights into the mode of action of 5c, morphological changes of C. albicans cells (ATCC 90028) were examined by SEM imaging (Fig. 4) . Untreated cells showed normal intact morphology with smooth cell surface whereas cells treated with 5c (0.8 µg ml
À1
) showed deformation including shrunken and collapsed morphology. Complete lysis of a few cells was also noticed. Results indicate that 5c exhibits anti-fungal activity by membrane destabilization.
Further, we evaluated the haemolytic activity of 5c on human erythrocytes. Erythrocytes were selected because of Table 1 . cont.
Compound
Chemical structure Activity at 10 µg ml the fragile nature of its outer membrane as compared to the robust cell wall of C. albicans. Haemolysis was quantified from a plot of haemolysis percentage against the logarithm concentration of 5c. Haemolytic concentration (HC 50 ) was considered as the inhibitor concentration which resulted in lysis of 50 % of erythrocytes. The HC 50 value determined from a plot of haemolysis percentage vs logarithmic concentration of 5c was 7.4 µg ml
À1
, which was much higher than the IC 50 value of 5c in C. albicans test strains including fluconazole-resistant clinical isolates (Fig. 4) . Finally, we determined the cytotoxicity of 5c in mammalian cells such as DU-145 and mouse skin fibroblast cell line using the MTT assay. The IC 50 value of 5c in DU-145 and fibroblast cells were 13.1and 41.2 µg ml À1 respectively, which was higher than the anti-fungal therapeutic dose (1.6-6.2 µg ml À1 ) of the compound for planktonic cells.
DISCUSSION
A new class of QACs, cationic lipo-oxazoles, was synthesized and evaluated for their anti-fungal activity. Cationic lipo-oxazoles with seven-and eight-carbon chains were found to inhibit the growth of several Candida strains and clinical isolates ( Table 1 ). The most active compound 5c was equally active against pairs of fluconazole-sensitive and resistant clinical isolates as well as non-albicans strains of Candida with MIC values ranging from 1.6 to 6.2 µg ml À1 ( Table 2 ). The cationic agents reportedly react with the phospholipid component in the cell membrane, thereby producing membrane distortions often leading to a complete loss of structural organization of the cells [21] .
Candida species present a serious threat in healthcare settings because of their ability to adhere to the substrate resulting in colonization and biofilm formation [41] . Candida biofilms consist of an intricate network of yeast, hyphae and pseudohyphae, with a subpopulation of persister cells that are recalcitrant to anti-fungal therapy [42] . We tested a new series of oxazole-containing QACs for their ability to inhibit Candida biofilms as they are reported to react with microbial cell membranes typically. Compound 5c could inhibit biofilm formation of Candida cells on a polystyrene surface, which is the most desirable property that conventional anti-fungals like azoles and polyenes lack. These molecules could, therefore, form the basis for the design of novel pharmacophores with potent antimicrobial activity, especially against drug-resistant isolates and microbial biofilms.
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